Shareprice
07 Nov 2025

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2023

25 July, 2023 Minutes from Extraordinary General Meeting in FluoGuide A/S News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Copenhagen, Denmark, 25 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held an extraordinary...
7 July, 2023 FluoGuide convenes an extraordinary general meeting News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
Copenhagen, Denmark, 7 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders...
5 July, 2023 FluoGuide completes a Directed Share Issue raising SEK 15 million News Corporate Action Shares Issuance English Regulatory MAR IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
20 June, 2023 FluoGuide announces positive interim results from phase IIa trial of FG001 in head & neck cancer News Corporate Information Other Corporate Information English IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
7 June, 2023 FluoGuide announces positive topline results from phase IIa trial of FG001 in lung cancer News Corporate Information Other Corporate Information English IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
31 May, 2023 FluoGuide A/S publishes interim report for the period January – March 2023 News English Regulatory Listing Regulation Report Interim Q1 IR
Copenhagen, Denmark, 31 May 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results...
24 May, 2023 FluoGuide provides update on strong clinical trial progress News Corporate Information Other Corporate Information English Regulatory MAR IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
21 March, 2023 FluoGuide awarded prestigious grant together with two academic partners News Corporate Information Other Corporate Information English Regulatory MAR IR
FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that Innovation Fund Denmark (Innovationsfonden)...
21 March, 2023 Minutes from Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR
Copenhagen, Denmark, 21 March 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...

FluoGuideCalendar & events